Novel T Cell Immunotherapies - Global and China Top Players Market Share and Ranking 2023
- Report Code : AMP2758959
- Published On: Oct, 2024
- Category : Healthcare & Pharma
- Pages : 139
-
According to latest Research, the global market for Novel T Cell Immunotherapies should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Novel T Cell Immunotherapies market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Novel T Cell Immunotherapies market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Lung Cancer grew percent to account for percent of the total market sales, and Breast Cancer grew percent.
This report studies and analyses global Novel T Cell Immunotherapies status and future trends, to help determine the Novel T Cell Immunotherapies market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Novel T Cell Immunotherapies, and provides market size (US$ million) and Year-over-Year growth, considering 2023 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Novel T Cell Immunotherapies market size, history data 2019-2024, and forecast data 2024-2029, (US$ million)
(2) Global Novel T Cell Immunotherapies by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(3) China Novel T Cell Immunotherapies by company, revenue, market share and industry ranking 2019-2024, (US$ million)
(4) Global Novel T Cell Immunotherapies key consuming regions, consumption value and demand structure
(5) Novel T Cell Immunotherapies industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Atara Biotherapeutics
Allovir
Eureka Therapeutics
Eutilex
Gammadelta Therapeutics
Neximmune
Ose Immunotherapeutics
Tevogen Bio
Windmil Therapeutics
Market segment by Type, covers
Activated T-cells
Virus Driven T-cells
Tregs
T-cell Vaccines
Others
Market segment by Application, can be divided into
Lung Cancer
Breast Cancer
Cytomegalovirus Infection
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Novel T Cell Immunotherapies product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Novel T Cell Immunotherapies market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 3: China Novel T Cell Immunotherapies market share and ranking of major manufacturers, revenue, 2019-2024
Chapter 4: Novel T Cell Immunotherapies industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions
-
With tables and figures helping analyze worldwide Novel T Cell Immunotherapies Global and China Top Players market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Market Overview1.1 Novel T Cell Immunotherapies Definition
1.2 Global Novel T Cell Immunotherapies Market Size and Forecast
1.3 China Novel T Cell Immunotherapies Market Size and Forecast
1.4 China Percentage in Global Market
1.5 Novel T Cell Immunotherapies Market Size: China VS Global Growth Rate, 2019-2030
1.6 Novel T Cell Immunotherapies Market Dynamics
1.6.1 Novel T Cell Immunotherapies Market Drivers
1.6.2 Novel T Cell Immunotherapies Market Restraints
1.6.3 Novel T Cell Immunotherapies Industry Trends
1.6.4 Novel T Cell Immunotherapies Industry Policy
2 Global Leading Players and Market Share2.1 By Revenue of Novel T Cell Immunotherapies, Global Market Share by Company, 2019-2024
2.2 Global Novel T Cell Immunotherapies Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Novel T Cell Immunotherapies Concentration Ratio
2.4 Global Novel T Cell Immunotherapies Mergers & Acquisitions, Expansion Plans
2.5 Global Novel T Cell Immunotherapies Major Companies Product Type
2.6 Head Office and Novel T Cell Immunotherapies Production Site of Key Manufacturer
3 China Leading Players, Market Share and Ranking3.1 By Revenue of Novel T Cell Immunotherapies, China Market Share by Company, 2019-2024
3.2 China Novel T Cell Immunotherapies Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis4.1 Novel T Cell Immunotherapies Industry Chain
4.2 Novel T Cell Immunotherapies Upstream Analysis
4.2.1 Novel T Cell Immunotherapies Core Raw Materials
4.2.2 Main Manufacturers of Novel T Cell Immunotherapies Core Raw Materials4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Novel T Cell Immunotherapies Production Mode
4.6 Novel T Cell Immunotherapies Procurement Model
4.7 Novel T Cell Immunotherapies Industry Sales Model and Sales Channels
4.7.1 Novel T Cell Immunotherapies Sales Model
4.7.2 Novel T Cell Immunotherapies Typical Distributors
5 Sights by Type5.1 Novel T Cell Immunotherapies Classification
5.1.1 Activated T-cells
5.1.2 Virus Driven T-cells
5.1.3 Tregs
5.1.4 T-cell Vaccines
5.1.5 Others5.2 By Type, Global Novel T Cell Immunotherapies Consumption Value & CAGR, 2019 VS 2024 VS 2030
5.3 By Type, Global Novel T Cell Immunotherapies Consumption Value, 2019-2030
6 Sights by Application6.1 Novel T Cell Immunotherapies Segment by Application
6.1.1 Lung Cancer
6.1.2 Breast Cancer
6.1.3 Cytomegalovirus Infection
6.1.4 Others6.2 By Application, Global Novel T Cell Immunotherapies Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Application, Global Novel T Cell Immunotherapies Consumption Value, 2019-2030
7 Sales Sights by Region7.1 By Region, Global Novel T Cell Immunotherapies Consumption Value, 2019 VS 2024 VS 2030
7.2 By Region, Global Novel T Cell Immunotherapies Consumption Value, 2019-2030
7.3 North America
7.3.1 North America Novel T Cell Immunotherapies & Forecasts, 2019-2030
7.3.2 By Country, North America Novel T Cell Immunotherapies Market Size Market Share7.4 Europe
7.4.1 Europe Novel T Cell Immunotherapies Market Size & Forecasts, 2019-2030
7.4.2 By Country, Europe Novel T Cell Immunotherapies Market Size Market Share7.5 Asia Pacific
7.5.1 Asia Pacific Novel T Cell Immunotherapies Market Size & Forecasts, 2019-2030
7.5.2 By Country/Region, Asia Pacific Novel T Cell Immunotherapies Market Size Market Share7.6 South America
7.6.1 South America Novel T Cell Immunotherapies Market Size & Forecasts, 2019-2030
7.6.2 By Country, South America Novel T Cell Immunotherapies Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level8.1 By Country, Global Novel T Cell Immunotherapies Market Size & CAGR, 2019 VS 2024 VS 2030
8.2 By Country, Global Novel T Cell Immunotherapies Consumption Value, 2019-2030
8.3 U.S.
8.3.1 U.S. Novel T Cell Immunotherapies Market Size, 2019-2030
8.3.2 By Type, U.S. Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.3.3 By Application, U.S. Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 20308.4 Europe
8.4.1 Europe Novel T Cell Immunotherapies Market Size, 2019-2030
8.4.2 By Type, Europe Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.4.3 By Application, Europe Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 20308.5 China
8.5.1 China Novel T Cell Immunotherapies Market Size, 2019-2030
8.5.2 By Type, China Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.5.3 By Application, China Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 20308.6 Japan
8.6.1 Japan Novel T Cell Immunotherapies Market Size, 2019-2030
8.6.2 By Type, Japan Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.6.3 By Application, Japan Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.7 South Korea
8.7.1 South Korea Novel T Cell Immunotherapies Market Size, 2019-2030
8.7.2 By Type, South Korea Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.7.3 By Application, South Korea Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.8 Southeast Asia
8.8.1 Southeast Asia Novel T Cell Immunotherapies Market Size, 2019-2030
8.8.2 By Type, Southeast Asia Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.8.3 By Application, Southeast Asia Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.9 India
8.9.1 India Novel T Cell Immunotherapies Market Size, 2019-2030
8.9.2 By Type, India Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.9.3 By Application, India Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 20308.10 Middle East & Africa
8.10.1 Middle East & Africa Novel T Cell Immunotherapies Market Size, 2019-2030
8.10.2 By Type, Middle East & Africa Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
8.10.3 By Application, Middle East & Africa Novel T Cell Immunotherapies Consumption Value Market Share, 2024 VS 2030
9 Company Profile9.1 Atara Biotherapeutics
9.1.1 Atara Biotherapeutics Company Information, Head Office, Market Area and Industry Position
9.1.2 Atara Biotherapeutics Company Profile and Main Business
9.1.3 Atara Biotherapeutics Novel T Cell Immunotherapies Models, Specifications and Application
9.1.4 Atara Biotherapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.1.5 Atara Biotherapeutics Recent Developments9.2 Allovir
9.2.1 Allovir Company Information, Head Office, Market Area and Industry Position
9.2.2 Allovir Company Profile and Main Business
9.2.3 Allovir Novel T Cell Immunotherapies Models, Specifications and Application
9.2.4 Allovir Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.2.5 Allovir Recent Developments9.3 Eureka Therapeutics
9.3.1 Eureka Therapeutics Company Information, Head Office, Market Area and Industry Position
9.3.2 Eureka Therapeutics Company Profile and Main Business
9.3.3 Eureka Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application
9.3.4 Eureka Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.3.5 Eureka Therapeutics Recent Developments9.4 Eutilex
9.4.1 Eutilex Company Information, Head Office, Market Area and Industry Position
9.4.2 Eutilex Company Profile and Main Business
9.4.3 Eutilex Novel T Cell Immunotherapies Models, Specifications and Application
9.4.4 Eutilex Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.4.5 Eutilex Recent Developments9.5 Gammadelta Therapeutics
9.5.1 Gammadelta Therapeutics Company Information, Head Office, Market Area and Industry Position
9.5.2 Gammadelta Therapeutics Company Profile and Main Business
9.5.3 Gammadelta Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application
9.5.4 Gammadelta Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.5.5 Gammadelta Therapeutics Recent Developments9.6 Neximmune
9.6.1 Neximmune Company Information, Head Office, Market Area and Industry Position
9.6.2 Neximmune Company Profile and Main Business
9.6.3 Neximmune Novel T Cell Immunotherapies Models, Specifications and Application
9.6.4 Neximmune Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.6.5 Neximmune Recent Developments
9.7 Ose Immunotherapeutics
9.7.1 Ose Immunotherapeutics Company Information, Head Office, Market Area and Industry Position
9.7.2 Ose Immunotherapeutics Company Profile and Main Business
9.7.3 Ose Immunotherapeutics Novel T Cell Immunotherapies Models, Specifications and Application
9.7.4 Ose Immunotherapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.7.5 Ose Immunotherapeutics Recent Developments
9.8 Tevogen Bio
9.8.1 Tevogen Bio Company Information, Head Office, Market Area and Industry Position
9.8.2 Tevogen Bio Company Profile and Main Business
9.8.3 Tevogen Bio Novel T Cell Immunotherapies Models, Specifications and Application
9.8.4 Tevogen Bio Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.8.5 Tevogen Bio Recent Developments
9.9 Windmil Therapeutics
9.9.1 Windmil Therapeutics Company Information, Head Office, Market Area and Industry Position
9.9.2 Windmil Therapeutics Company Profile and Main Business
9.9.3 Windmil Therapeutics Novel T Cell Immunotherapies Models, Specifications and Application
9.9.4 Windmil Therapeutics Novel T Cell Immunotherapies Revenue and Gross Margin, 2019-2024
9.9.5 Windmil Therapeutics Recent Developments
10 Conclusion
11 Appendix11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources11.3 Market Estimation Model
11.4 Disclaimer
-
The Novel T Cell Immunotherapies Global and China Top Players Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
Recognize the areas along the Novel T Cell Immunotherapies Global and China Top Players Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
Depending upon the type of applications, the Novel T Cell Immunotherapies Global and China Top Players Market has been segmented into
The Novel T Cell Immunotherapies Global and China Top Players Market is expected to reach a reasonable valuation by 2029; now the market is expected to shift its focus from growth to value.
According to the Novel T Cell Immunotherapies Global and China Top Players Market research paper, organizations are making more progress than their supply chain counterparts, including suppliers.
In this highly competitive and rapidly evolving Novel T Cell Immunotherapies Global and China Top Players Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
